Type 1 interferons as a potential treatment against COVID-19

Please use this identifier to cite or link to this item: http://repositorio.ufla.br/jspui/handle/1/41214

metadata.artigo.dc.title:	Type 1 interferons as a potential treatment against COVID-19
metadata.artigo.dc.creator:	Sallard, Erwan Lescure, François-Xavier Yazdanpanah, Yazdan Mentre, France Peiffer-Smadja, Nathan
metadata.artigo.dc.subject:	Interferon COVID-19 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
metadata.artigo.dc.publisher:	Elsevier
metadata.artigo.dc.date.issued:	Jun-2020
metadata.artigo.dc.identifier.citation:	SALLARD, E. et al. Type 1 interferons as a potential treatment against COVID-19. Antiviral Research, [S.l.], v. 178, June 2020.
metadata.artigo.dc.description.abstract:	Type 1 interferons have a broad antiviral activity in vitro and are currently evaluated in a clinical trial to treat MERS-CoV. In this review, we discuss preliminary data concerning the potential activity of type 1 interferons on SARS-CoV-2, and the relevance of evaluating these molecules in clinical trials for the treatment of COVID-19.
metadata.artigo.dc.identifier.uri:	https://www.sciencedirect.com/science/article/pii/S0166354220302059 http://repositorio.ufla.br/jspui/handle/1/41214
metadata.artigo.dc.language:	en_US
Appears in Collections:	FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)

Files in This Item:

There are no files associated with this item.